Nexscient Financials
Nexscient (NXNT) reported $1.1M in revenue over the twelve months to Jun 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
NXNT’s visible mechanic is development-stage spending, while FY2025 losses coincide with liabilities exceeding assets and negative equity.
The cash conversion gap is visible in FY2025: operating cash flow was-$408K , less negative than net income of-$530K , so the accounting loss was not a one-for-one cash outflow. Because depreciation and amortization was only$20K , the remaining difference points to working-capital or other timing items, leaving cash generation and reported earnings telling different stories.
Equity moved from
R&D fell by more than half between FY2024 and FY2025, while FY2025 SG&A was about 4.0x R&D and interest expense added
Financial Health Signals
Nexscient does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Nexscient passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 3 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
Nexscient reported a net loss of $530K while operations used $408K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Nexscient generated $0 in revenue in fiscal year 2025.
Nexscient reported -$530K in net income in fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Nexscient held $100K in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
None of these metrics is reported for fiscal year 2025.
Capital Allocation
Nexscient invested $97K in research and development in fiscal year 2025. This represents a decrease of 52.6% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
NXNT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $673K | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| Gross Profit | $437K | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| R&D Expenses | $23K+228.6% | $7K-33.3% | $11K0.0% | $11K0.0% | $11K | $0-100.0% | $10K-85.7% | $70K |
| SG&A Expenses | $659K+507.8% | $108K-14.6% | $127K-12.1% | $144K+63.4% | $88K-18.2% | $108K-27.8% | $150K+159.2% | $58K |
| Operating Income | -$380K | N/A | N/A | N/A | -$99K | N/A | N/A | N/A |
| Interest Expense | $20K+73.7% | $12K-2.2% | $12K-0.2% | $12K+40.7% | $9K+32.0% | $6K | $0 | $0 |
| Income Tax | -$2K | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| Net Income | -$430K-238.3% | -$127K+14.9% | -$149K+10.5% | -$167K-55.4% | -$107K+20.3% | -$135K+15.6% | -$160K-25.2% | -$128K |
| EPS (Diluted) | -$0.01 | -$0.01 | N/A | N/A | -$0.010.0% | -$0.010.0% | -$0.01 | N/A |
NXNT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.7M+379.7% | $976K+239.4% | $288K+22.1% | $235K-21.9% | $302K+66.8% | $181K+91.0% | $95K-48.4% | $184K |
| Current Assets | $1.3M+59.7% | $808K+602.2% | $115K+16.4% | $99K-38.3% | $160K+360.6% | $35K-56.0% | $79K-51.7% | $163K |
| Cash & Equivalents | $489K-35.2% | $755K+2552.9% | $28K-51.7% | $59K-41.3% | $100K+370.0% | $21K-73.0% | $79K-47.8% | $151K |
| Accounts Receivable | $493K | N/A | $0 | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $2.6M | N/A | $0 | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $2.5M+198.8% | $849K+8.4% | $784K+17.5% | $667K+17.8% | $566K+42.6% | $397K+32.2% | $300K+30.9% | $229K |
| Current Liabilities | $1.8M+185.5% | $622K+28.1% | $486K+368.6% | $104K+59.7% | $65K+23.4% | $53K+92.5% | $27K-42.9% | $48K |
| Long-Term Debt | $297K | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $2.1M+1592.0% | $127K+125.5% | -$496K-14.9% | -$432K-63.1% | -$265K-22.4% | -$216K-5.1% | -$206K-348.6% | -$46K |
| Retained Earnings | -$2.4M-21.5% | -$2.0M-6.8% | -$1.9M-8.7% | -$1.7M-10.7% | -$1.6M-7.4% | -$1.5M-10.2% | -$1.3M-13.8% | -$1.2M |
Not reported in any period shown, so not listed: Inventory.
NXNT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | -$23K+42.0% | -$40K+55.8% | -$92K-123.7% | -$41K+61.1% | -$105K+33.2% | -$157K-50.8% | -$104K |
| Investing Cash Flow | N/A | N/A | N/A | N/A | $528K | N/A | N/A | N/A |
| Financing Cash Flow | N/A | $750K+7400.0% | $10K-80.0% | $50K+112.3% | -$408K-528.9% | $95K+11.8% | $85K-52.8% | $180K |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
NXNT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.4% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -34.2% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | -38.8% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | -20.1%+80.4pp | -100.4% | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -9.2%+3.8pp | -13.0%+39.0pp | -52.0%+18.9pp | -70.9%-35.3pp | -35.6%+38.9pp | -74.6%+94.2pp | -168.8%-99.2pp | -69.5% |
| Current Ratio | 0.73-0.6x | 1.30+1.1x | 0.24-0.7x | 0.95-1.5x | 2.47+1.8x | 0.66-2.2x | 2.89-0.5x | 3.42 |
| Debt-to-Equity | 0.14-6.6x | 6.70 | N/A | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: FCF Margin.
Note: Shareholder equity is negative (-$265K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Where Nexscient Ranks
Frequently Asked Questions
What is Nexscient's annual revenue?
Nexscient (NXNT) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Nexscient profitable?
No, Nexscient (NXNT) reported a net income of -$530K in fiscal year 2025.
What is Nexscient's operating cash flow?
Nexscient (NXNT) recorded an outflow of $408K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Nexscient's total assets?
Nexscient (NXNT) had $302K in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Nexscient spend on research and development?
Nexscient (NXNT) invested $97K in research and development during fiscal year 2025.
What is Nexscient's current ratio?
Nexscient (NXNT) had a current ratio of 2.47 as of fiscal year 2025, which is generally considered healthy.
What is Nexscient's return on assets (ROA)?
Nexscient (NXNT) had a return on assets of -175.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Why is Nexscient's debt-to-equity ratio negative or not reported?
Nexscient (NXNT) has negative shareholder equity of -$265K as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Nexscient's Piotroski F-Score?
Nexscient (NXNT) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nexscient's earnings high quality?
Nexscient (NXNT) reported a net loss of $530K while operations used $408K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.